Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up
Pharmaceutical & Life Sciences News
View and Filter All Stories

Latest Stories

The IPO Bust Blew a $575 Million Hole in Law Firm Revenue

A mere 66 companies reported paying their lawyers $64 million for work on IPO registrations through the first three quarters of the year, according to data compiled by Bloomberg and an analysis by Bloomberg Law. That’s $575 million less in lawyer fees for firms, and just 10% of the amount from a year ago.

OpenSky ‘Abuse’ Sanctions Add New Weapons in Patent Challenges

A landmark sanctions decision from the US Patent and Trademark Office director in a high-profile patent review gives the agency and attorneys new avenues to combat abuse of its procedures, even as it leaves open questions about whether the precedent does enough to discourage future patent challengers from seeking a “windfall.”

In Since-Sealed Order, Clues on Timing of Teva’s Cabometyx Copy

An order mistakenly filed publicly in Exelixis Inc.'s patent-infringement dispute over Teva Pharmaceutical Industries Ltd.'s proposed copy of its blockbuster cancer drug Cabometyx revealed details of a longer runway for the potential launch of Teva’s cheaper version of the treatment.

Texas Justices Mull Liability Claims Over Nursing Home Fall

Texas Supreme Court justices Wednesday questioned whether a lawsuit filed over an elderly woman’s fall while living at a nursing home in Collin County included a premise liability or a health care liability claim, which could determine whether the plaintiffs can proceed after they allegedly missed a statutory deadline.

View More

Covid-19 Vaccine: Can Your Employer Make You Take It?

As employers are making plans to return to their workplaces. How quickly they succeed will likely depend on how many of their employees get vaccinated.

Up Next

Coronavirus Is Changing the Way Lawyers Work

PFAS: The 'Forever Chemicals'